Ivan Urits, MD
Pain Medicine · Wareham, MANPI 1346635422
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Boston Scientific at 43.1% of the total. Among pain medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 674 payments — averaging $103.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$30K
- Vertex$17K
- MML US, Inc.$3K
- Nevro Corp.$3K
- Medtronic$3K
- Painteq LLC$3K
- plus $11K from 28 others
What the payments were for
- Consulting fees$6,2009%
- Speaking & faculty fees$26,96339%
- Travel & lodging$8,44412%
- Food & beverage$26,98439%
- Education$1,0592%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 183 | $29,985 |
| Vertex | 20 | $16,701 |
| MML US, Inc. | 23 | $3,103 |
| Nevro Corp. | 102 | $2,986 |
| Medtronic(2 entities) | 28 | $2,893 |
| Painteq LLC | 26 | $2,501 |
| Saluda Medical Americas, Inc. | 29 | $1,680 |
| Abbott | 15 | $1,436 |
| Nalu Medical, Inc. | 21 | $1,281 |
| Spinal Simplicity, LLC | 4 | $1,071 |
| Pacira Pharmaceuticals Incorporated | 3 | $815 |
| AbbVie | 68 | $733 |
| Stryker | 7 | $688 |
| Stimwave Technologies Incorporated | 9 | $523 |
| Vertos Medical, Inc. | 8 | $451 |
| SPR Therapeutics, Inc | 9 | $389 |
| Globus Medical | 20 | $358 |
| Biotronik NRO, Inc. | 2 | $324 |
| Valinor Pharma, LLC | 21 | $304 |
| Curonix LLC | 3 | $255 |
| Biohaven Pharmaceuticals, Inc. | 19 | $226 |
| Pfizer | 17 | $212 |
| Lilly USA, LLC | 9 | $173 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $154 |
| Cala Health, Inc. | 1 | $117 |
| Relievant Medsystems, Inc. | 2 | $100 |
| Biodelivery Sciences International, Inc. | 2 | $35 |
| Spinefrontier, Inc. | 1 | $32 |
| Eisai Inc. | 1 | $31 |
| Livanova USA, Inc. | 1 | $27 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
| AstraZeneca | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| GRT US Holding, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JOURNAVX$16,517
- WaveWriter Alpha Prime 16$9,992
- WAVEWRITER ALPHA$7,581
- GENERAL - THERAPIES$4,308
- ReActiv8$2,856
- GENERAL PAIN MANAGEMENT$2,786
- PAINTEQ$1,796
- VenaSeal$1,468
- SPECTRA WAVEWRITER$1,156
- HA MINUTEMAN G3-R$976
- Iovera$775
- Zilretta$775
- PROCLAIM$772
- Nalu Neurostimulation System$677
- Evoke$633
- Omnia$521
- SPINEJACK$461
- Evoke SCS$460
- StimQ Receiver Stimulator Kit Channel A US w Receiver$411
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$411
How this compares
$69,649 in reported general payments places this provider in the 95th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 225 | $194,126 |
| Buprenorphine | 696 | $162,866 |
| MovantikNaloxegol Oxalate | 58 | $44,226 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 233 | $39,507 |
| Xtampza ErOxycodone Myristate | 31 | $24,481 |
| OxycontinOxycodone Hcl | 29 | $24,273 |
| Gabapentin | 1,179 | $23,720 |
| Lidocaine | 169 | $22,384 |
| UbrelvyUbrogepant | 17 | $21,981 |
| LinzessLinaclotide | 11 | $14,698 |
| QuliptaAtogepant | 13 | $14,098 |
| Tramadol Hcl | 1,057 | $10,708 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 500 | $10,288 |
| Pregabalin | 427 | $8,309 |
| Diclofenac Sodium | 220 | $8,102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Linzess, Qulipta | $733 | $50,77741 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 137 pain medicine providers in Massachusetts.
Other pain medicine in Wareham
- Hariharan SundramNewton$1.7M
- Thomas SimopoulosBoston$181K
- Antje BarreveldNewton$64K
- Arti OriBoston$62K
- Christine SangBoston$56K
- Ali EbrahimiBurlington$41K
- Alexandra AdlerLowell$35K
- Eduard VaynbergBoston$32K
- David GarasNatick$21K
- Daniel VardehEast Sandwich$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.